Top Markets
#1 Talus Network Talus Network +31.64%
#2 Starpower Starpower +31.04%
#3 Brevis Brevis +30.27%
#4 Keep Network Keep Network +29.44%
#5 Tung Tung Tung Sahur Tung Tung Tung Sahur +25.54%
#6 MemeCore MemeCore +24.60%
#7 Infinity Ground Infinity Ground +22.45%
#8 Allora Allora +21.35%
#9 屎壳郎 (Dung Beetle) 屎壳郎 (Dung Beetle) +17.45%
#10 DeepBook DeepBook +17.40%
Coin of the day
Talus Network Talus Network
Setări
Limbă
ROMâNă
Monedă
USD
Temă
IntegraGen SA IntegraGen SA

IntegraGen SA

ALINT
Rang în acțiuni #19673
IntegraGen SA provides human genome analysis services for academic researcher... IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; SIRIUS, a cloud-based software tool that enables researchers to analyze whole genome, whole exome, and gene panel sequencing data; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was founded in 2000 and is headquartered in Évry, France. IntegraGen SA is a subsidiary of OncoDNA SA.
Preț acțiune
$0.20876331
Capitalizare de piață
$1.38M
Schimbare (1 zi)
1.15%
Schimbare (1 an)
-64.84%
Țară
FR
Tranzacționează IntegraGen SA (ALINT)

Categorie

Healthcare
Raport P/S pentru IntegraGen SA (ALINT)
Raport P/S la data de July 2026 TTM: 0.23
Conform celor mai recente rapoarte financiare și prețului acțiunilor IntegraGen SA, raportul P/S actual (TTM) este 0.23. La sfârșitul anului 2023, compania avea un P/S de 0.47.
Istoricul raportului P/S pentru IntegraGen SA din 2008 până în 2026
Raport P/S la sfârșitul fiecărui an
An Raport P/S Schimbă
2026 (TTM) 0.23 -48.57%
2024 0.44 -7.21%
2023 0.47 -22.57%
2022 0.61 -5.95%
2021 0.65 -57.32%
2020 1.52 91.72%
2019 0.79 -23.34%
2018 1.03 -58.87%
2017 2.51 -7.49%
2016 2.71 -30.91%
2015 3.93 -9.01%
2014 4.32 23.38%
2013 3.50 -42.44%
2012 6.08 -6.36%
2011 6.49 -5.08%
2010 6.84 -28.72%
2009 9.59 -19.67%
2008 11.94 0.00%
Raport P/S pentru companii similare sau competitoare
Companie Raport P/S Diferență raport P/S Țara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
4.26 1,784.05%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.29 4,445.91%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
4.31 1,802.61%
US
UCB SA UCB SA
UCB SA
UCB.BR
6.44 2,747.06%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
16.96 7,394.12%
NL